Last updated 2026-07-20
- Raised $8M Series A led by Avigdor Orlinsky, Mar 2022
- Raised $8M Seed round, Dec 2017
- Develops saliva tests for HIV and high-risk pregnancy, Jun 2026
Total raised
$16.0M
Last: A Round 2022-04
Stage
Series A
Founded
2016
Headcount
13
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
Salignostics is an Israeli startup that develops cutting-edge saliva-based rapid diagnostic tests (RDT) for various conditions, including pregnancy, COVID-19, and other infectious diseases. The company's innovative platform overcomes the challenges of saliva-based testing by amplifying biomarkers, neutralizing blocking agents, and standardizing sample volumes, making diagnostics faster, safer, and more cost-effective. Their vision is to transform in-vitro diagnostics by developing easy, clean, safe, low-cost, accessible, and reliable saliva-based products for global healthcare providers, home-testing markets, and laboratories.
Funding history · 2 rounds · $16.0M total
2022-03
A Round
$8.0M
★ Avigdor Orlinsky
2017-12
Seed
$8.0M
Headcount over time
From 2 (2019-02) to 9 (2026-03) · +7 (+350%) · 7 points · source: Finder history + radar grounding
Q&A
- What is Salignostics' primary focus in the diagnostics market?
- Salignostics is an Israeli company focused on pioneering saliva-based rapid diagnostic tests, aiming to transform saliva into a reliable body fluid for immunoassays across various conditions.
- When was Salignostics founded and where is its headquarters located?
- Salignostics was founded in 2016 and is headquartered in Jerusalem, Israel.
- What was Salignostics' most recent funding round and who were the lead investors?
- Salignostics completed a Series A funding round in April 2022, raising $8,000,000. The lead investor was Avigdor Orlinsky.
- How much total funding has Salignostics raised to date?
- Salignostics has raised a total of $22,000,000 in funding.
- What is the employee count for Salignostics?
- Salignostics has an employee count in the 11-50 range.
- Which organization provided a grant to Salignostics in June 2026?
- The Bill & Melinda Gates Foundation provided a grant of $1,870,000 to Salignostics in June 2026.
- What new saliva tests is Salignostics developing, according to June 2026 news?
- According to June 2026 news, Salignostics is developing saliva tests for HIV and high-risk pregnancy.
- When did Salignostics begin selling its saliva-based pregnancy test in Germany?
- Salignostics started selling its saliva-based pregnancy test in Germany in December 2025.
Team · 7
Prof. Aaron Palmon
Founder · Co-Founder, President
Dr. Omer Deutsch
Founder · Co-Founder, CEO
Dr. Guy Krief
Founder · Co-Founder, Deputy CEO
Dr. Raluca Cohen
Founder · Co-Founder, CSO
Dr. Yoav Neumann
Founder · Co-Founder, CFO
Noam Band
CBDO
Commercial Development Manager
Sectors & technology
Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Business model
B2BB2CB2G
Highlights
Patents
Tags
saliva-diagnosticsrapid-diagnostic-testsmedtechbiotechhealthtechin-vitro-diagnosticshome-diagnosticspoint-of-carehiv-diagnosticsmaternal-health-diagnosticssaliva-based-diagnostics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | salignostics.com/ |
|---|---|
| linkedin.com/company/salignostics/ |
Identifiers & details
| Legal name | Salignostics Ltd. |
|---|---|
| Founded | 2016 |
| Employees (exact) | 13 |
Radar intelligence
Patents
| EPO | 3 |
|---|
Publications (Crossref)
| Works | 1 |
|---|
Web history (Wayback)
| Domain | salignostics.com |
|---|
Certificate / subdomain footprint
| Subdomains | 9 |
|---|